Brief: Ventyx Provides Clinical And Corporate Updates
Dec 2 (Reuters) - Ventyx Biosciences Inc VTYX.O: VENTYX PROVIDES CLINICAL AND CORPORATE UPDATES VENTYX BIOSCIENCES INC: REVISING GUIDANCE FOR TOPLINE DATA RELEASE FROM INTERIM ANALYSIS OF PHASE 2 RP TRIAL TO Q1 2026 Source text: ID:nGNX3ykgBd Further company coverage: VTYX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ventyx Biosciences
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (updated)
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Deals of the day-Mergers and acquisitions